Feigeres, France

Samir Cherkaoui

This inventor holds 14 USPTO granted patents and 12 published patent applications, plus 2 CIPO patents and 2 EPO patents, primarily in Microvesicle Technology. Top assignees: Bracco Suisse Sa, Bracco International Bv, Other. Active years: 2010-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Samir Cherkaoui. Retrieved from https://idiyas.com/inventor/samir-cherkaoui

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 14 

% Patents Active = 85.7

 

 

Average Co-Inventor Count = 4.8

ph-index = 3

Forward Citations = 33(Granted Patents)


Company Filing History:


Years Active: 2010-2026

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Gas-Filled Microvesicles
Calibrated Microvesicles
Cationic Microvesicles
Chimeric Proteins
Selectins Targeting
Microparticle Preparation
Targeting Vectors
Phospholipid Conjugates
Targeting Constructs
14 patents (USPTO):Explore Patents

Title: Samir Cherkaoui: Innovator in Microvesicle Technology

Introduction

Samir Cherkaoui is a prominent inventor based in Feigeres, France. He has made significant contributions to the field of biotechnology, particularly in the development of innovative microvesicle technologies. With a total of 12 patents to his name, Cherkaoui's work has the potential to impact various applications in diagnostics and therapeutics.

Latest Patents

Cherkaoui's latest patents include groundbreaking inventions such as cationic calibrated-size gas-filled microvesicles. This invention relates to new microvesicles that bear an overall positive charge and have a geometric standard deviation (GSD) value of at least 1.25 or lower. The microvesicles are manufactured using a stabilizing envelope comprising an amphiphilic material, which includes a cationic lipid and a neutral or cationic amphiphilic polymeric compound. Another notable patent is for a recombinant chimeric protein designed for selectins targeting. This chimeric protein comprises a Selectin Binding domain and a non-covalent dimerization domain, allowing for efficient expression in mammalian systems and enabling in vivo and in vitro targeting for diagnostic or therapeutic purposes.

Career Highlights

Throughout his career, Samir Cherkaoui has worked with notable companies such as Bracco Suisse SA and Bracco International BV. His experience in these organizations has contributed to his expertise in the field of biotechnology and innovation.

Collaborations

Cherkaoui has collaborated with esteemed colleagues, including Philippe Bussat and Bernard Lamy. These partnerships have further enriched his research and development efforts.

Conclusion

Samir Cherkaoui is a distinguished inventor whose work in microvesicle technology and recombinant proteins showcases his innovative spirit and dedication to advancing biotechnology. His contributions are poised to make a lasting impact in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…